Enhancement of pharmacist role for the management of Chronic Obstructive Pulmonary Disease (COPD) in Pakista
- Conditions
- Chronic obstructive pulmonary diseaseRespiratory - Chronic obstructive pulmonary disease
- Registration Number
- ACTRN12622000234718
- Lead Sponsor
- Amjad Khan
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 120
Patients only attend the outpatient COPD wards, confirmed diagnosis of COPD by the hospital consultant for at least 1 year with a forced expiratory volume in 1 s (FEV1) of 30–80% of the predicted normal value, patients that hospital consultant agree that the patient is suitable for entering the trial will be included in this study.
Patients will be excluded from the study if they will have moderate to severe learning difficulties, mobility problems, confusion, disorientation or terminal illness, congestive heart failure or if they are attending a pulmonary rehabilitation programs consulting a pulmonary nurse or clinical pharmacist in the last 6 month will be excluded.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.